This resolution recognizes the Islamic holy month of Ramadan and extends well wishes to Muslims in the United States and globally for Eid al-Fitr. It formally acknowledges the significance of Ramadan as a period of fasting, spiritual renewal, and reflection for over 2 billion Muslims worldwide. The document highlights the contributions of American Muslims to society, including their roles in the military, government, and various professional fields. This is a symbolic gesture of respect and solidarity rather than a law that changes policy or requires funding.
This bill, titled the No Bailout for Crypto Act, prohibits the U.S. government from providing financial assistance to companies and systems involved in digital asset activities to prevent their failure or bankruptcy. It specifically bars Federal agencies from using emergency liquidity facilities, the Exchange Stabilization Fund, or other taxpayer resources to support digital asset intermediaries, decentralized finance protocols, or regulated financial service providers operating in the digital asset space. The legislation aims to establish a clear rule that digital asset market participants cannot receive taxpayer-funded bailouts, while maintaining the Federal Reserve's existing authority to lend to traditional depository institutions.
This bill, titled the Forever Chemical Regulation and Accountability Act of 2026, aims to reduce and eventually eliminate the production and use of perfluoroalkyl and polyfluoroalkyl substances, commonly known as PFAS or forever chemicals. It requires manufacturers and users to report their PFAS activities annually and mandates a 10-year phaseout of nonessential uses, with specific timelines for banning PFAS in products like carpets, food packaging, cosmetics, and apparel. The bill also prohibits all releases of PFAS above detection thresholds after 10 years, establishes research centers to develop detection and remediation technologies, and extends legal protections for victims of PFAS exposure by modifying bankruptcy and statute of repose rules.
This bill, the Fertilizer Transparency Act of 2026, would require manufacturers and wholesalers of fertilizer to report weekly price and quantity data to the U.S. Department of Agriculture. The reporting would apply to nitrogen, phosphorus, potassium, and fertilizer products sold in the United States, with separate data categories for domestic and foreign companies. Cooperatives and non-manufacturer retailers would be exempt from mandatory reporting but could choose to report voluntarily. The collected information would be published weekly on a public dashboard to help farmers and market participants make more informed marketing decisions and promote competition in the fertilizer industry.
This bill directs the U.S. Trade Representative to investigate whether Canada's Online Streaming Act unfairly targets American streaming companies by imposing discriminatory taxes and content requirements. It authorizes the Trade Representative to consult with affected U.S. businesses and trade partners, then potentially take retaliatory trade actions if Canada does not amend the measures. The legislation also requires regular reporting to Congress on Canada's implementation of these policies and extends similar investigative powers to other countries with comparable digital trade restrictions.
This bill, known as the Keep Innovators in America Act, modifies immigration rules for international students in the United States. It allows students on F-1 visas to work in their field of study after completing their degree requirements, provided the Department of Homeland Security approves the terms. The legislation also permits these students to maintain their student status while their family petitions for permanent residency are pending or approved. These changes aim to extend work opportunities for international graduates without altering their primary student visa classification.
This bill establishes the SECURE Health Act to strengthen the global health workforce by creating a coordinated federal strategy to train, support, and protect frontline health workers worldwide. It requires the President to develop a five-year Global Health Workforce Strategy, appoint a dedicated coordinator within the State Department, and form an interagency task force to align health investments across federal agencies. The legislation mandates detailed annual reporting on funding for health worker salaries, training, and protection measures, while also calling for an independent global report every two years to track progress. Additionally, the bill emphasizes integrated funding approaches that support multiple health needs rather than single-disease programs and requires host countries to contribute to salary support plans to ensure long-term sustainability.
This bill establishes a federal task force to address maternal health disparities by coordinating efforts across multiple government agencies and community stakeholders to reduce preventable maternal deaths and serious health complications. The task force will include representatives from various departments such as Health and Human Services, Housing and Urban Development, and Transportation, along with community leaders, patients, and healthcare providers focused on maternal health. Additionally, the bill authorizes $100 million over five years to provide grants to community organizations for addressing social determinants of maternal health including housing, transportation, nutrition, employment, and environmental conditions. These grants prioritize areas with high rates of maternal mortality and poverty, and recipients must submit annual reports on their activities and outcomes. The legislation defines key terms such as maternal mortality and social determinants of maternal health to guide implementation and reporting requirements.
The SILVER Act aims to improve the resilience and efficiency of the U.S. precious metals futures market by allowing storage facilities outside New York City to be approved for use in futures contracts. The bill requires derivatives clearing organizations to use transparent, objective criteria when selecting storage vaults and to approve new facilities that promote geographic diversity, competition, and lower storage costs. It mandates that at least two approved depositories be available in each of the four U.S. time zones, ensuring broader market access and reducing risks associated with concentrating vaults in one location. The legislation also requires periodic assessments of how easily market participants can access physical delivery of commodities regardless of where the storage facilities are located.
This bill expands federal labor protections to incarcerated workers by explicitly including them under the Fair Labor Standards Act, regardless of whether they work in publicly or privately operated correctional facilities. It defines these workers as individuals performing labor within prison programs, work release initiatives, or facility operations, and clarifies that they are employed by either the public agency or the private contractor running the facility. A key provision allows employers to deduct the cost of board, lodging, and certain court-imposed fees from an incarcerated worker's wages without counting these deductions against minimum wage requirements. The legislation also specifies which fees qualify for deduction, such as court surcharges and filing costs, while explicitly excluding payments for child support, victim compensation, civil judgments, and criminal fines.
This bill proposes to add 7-hydroxymitragynine to Schedule I of the Controlled Substances Act, classifying it as a controlled substance. The legislation specifically excludes naturally occurring 7-hydroxymitragynine found in kratom plants from this classification while including synthetic versions. This change would require federal regulation of synthetic forms of the compound but would not affect kratom products containing the substance in its natural state. The bill directly impacts pharmaceutical manufacturers and synthetic drug producers who would need to comply with new federal scheduling requirements.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
